1. Home
  2. HCM vs ADUS Comparison

HCM vs ADUS Comparison

Compare HCM & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • ADUS
  • Stock Information
  • Founded
  • HCM 2000
  • ADUS 1979
  • Country
  • HCM Hong Kong
  • ADUS United States
  • Employees
  • HCM N/A
  • ADUS N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • ADUS Medical/Nursing Services
  • Sector
  • HCM Health Care
  • ADUS Health Care
  • Exchange
  • HCM Nasdaq
  • ADUS Nasdaq
  • Market Cap
  • HCM 2.3B
  • ADUS 2.2B
  • IPO Year
  • HCM N/A
  • ADUS 2009
  • Fundamental
  • Price
  • HCM $16.11
  • ADUS $109.23
  • Analyst Decision
  • HCM Hold
  • ADUS Buy
  • Analyst Count
  • HCM 1
  • ADUS 10
  • Target Price
  • HCM $19.00
  • ADUS $135.30
  • AVG Volume (30 Days)
  • HCM 71.4K
  • ADUS 170.9K
  • Earning Date
  • HCM 03-19-2025
  • ADUS 02-24-2025
  • Dividend Yield
  • HCM N/A
  • ADUS N/A
  • EPS Growth
  • HCM N/A
  • ADUS 23.71
  • EPS
  • HCM N/A
  • ADUS 4.37
  • Revenue
  • HCM $610,806,000.00
  • ADUS $1,133,806,000.00
  • Revenue This Year
  • HCM N/A
  • ADUS $10.71
  • Revenue Next Year
  • HCM $15.89
  • ADUS $24.57
  • P/E Ratio
  • HCM N/A
  • ADUS $24.85
  • Revenue Growth
  • HCM N/A
  • ADUS 10.15
  • 52 Week Low
  • HCM $12.84
  • ADUS $85.94
  • 52 Week High
  • HCM $21.92
  • ADUS $136.72
  • Technical
  • Relative Strength Index (RSI)
  • HCM 68.69
  • ADUS 25.48
  • Support Level
  • HCM $13.58
  • ADUS $112.91
  • Resistance Level
  • HCM $13.96
  • ADUS $117.07
  • Average True Range (ATR)
  • HCM 0.31
  • ADUS 2.86
  • MACD
  • HCM 0.34
  • ADUS -0.98
  • Stochastic Oscillator
  • HCM 89.84
  • ADUS 5.95

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Share on Social Networks: